| Ticker | STOK |
|---|---|
| ISIN | US86150R1077 |
| Sector | Tecnología |
| Mercado | NASDAQ |
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and...
El precio actual de Stoke Therapeutics, Inc (STOK) es de 33,71 , con una variación del -0,94%.
Stoke Therapeutics, Inc opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones